Sven Sandin is associate professor of psychiatry and a member of the Seaver Autism Center for Research and Treatment at the Icahn School of Medicine at Mount Sinai and a statistician in the medical epidemiology and biostatistics department at the Karolinska Institutet. He has more than 20 years of experience with epidemiological studies, primarily using the Swedish and Nordic population-based national registers to characterize the genetic basis of autism and familial recurrence of autism.
Sven Sandin
Associate professor of psychiatry
Icahn School of Medicine at Mount Sinai
From this contributor
By
Sneha Chaturvedi, John Constantino, Natasha Marrus, Sven Sandin, Benjamin Yip
19 September 2024
6 min read
Autism is more heritable in boys than in girls
If boys have greater inherited liability for autism, the female protective effect may not fully explain the sex difference in prevalence.
Autism is more heritable in boys than in girls
By
Sneha Chaturvedi, John Constantino, Natasha Marrus, Sven Sandin, Benjamin Yip
19 September 2024 | 6 min read
Explore more from The Transmitter
From friend to foe: How the brain updates feelings toward others
A specific hippocampus-to-amygdala pathway reassigns emotional valence to a known individual, whereas the hippocampus’s own representation of that individual’s identity remains stable.
From friend to foe: How the brain updates feelings toward others
A specific hippocampus-to-amygdala pathway reassigns emotional valence to a known individual, whereas the hippocampus’s own representation of that individual’s identity remains stable.
By
Natalia Mesa
9 July 2026 | 5 min read
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
By
Kenneth Harris
9 July 2026 | 9 min read
Neuropathologist not guilty of research misconduct, says university probe
The investigation determined that seven papers by corresponding author Adriano Aguzzi have “scientifically significant” errors, which Aguzzi attributes to his former students.
Neuropathologist not guilty of research misconduct, says university probe
The investigation determined that seven papers by corresponding author Adriano Aguzzi have “scientifically significant” errors, which Aguzzi attributes to his former students.
By
Dalmeet Singh Chawla
8 July 2026 | 5 min read